Stocks › HUMA

Humacyte, Inc.

HUMA·Nasdaq·United States United States·USD
$0.45
-0.10 (-17.90%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
HUMA
Humacyte, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HUMAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of HUMA by members of U.S. Congress · 17 on record · 5 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Sale
$1,001 - $15,000
Aug 5, 2026 May 3, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$1,001 - $15,000
Aug 5, 2026 Mar 21, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$1,001 - $15,000
Aug 5, 2026 Mar 21, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$15,001 - $50,000
Aug 5, 2026 Mar 21, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Sale
$15,001 - $50,000
Aug 5, 2026 May 3, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Sale
$15,001 - $50,000
Jun 14, 2024 May 3, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Sale
$1,001 - $15,000
Jun 14, 2024 May 3, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Sale
$50,001 - $100,000
May 15, 2024 Apr 30, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$1,001 - $15,000
Apr 15, 2024 Mar 21, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$15,001 - $50,000
Apr 15, 2024 Mar 21, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$1,001 - $15,000
Apr 15, 2024 Mar 21, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$15,001 - $50,000
Mar 15, 2024 Feb 12, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Sale
$1,001 - $15,000
Feb 14, 2024 Jan 19, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$1,001 - $15,000
Aug 14, 2023 Jul 25, 2023 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$1,001 - $15,000
Aug 14, 2023 Jul 25, 2023 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$1,001 - $15,000
Aug 14, 2023 Jul 25, 2023 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL HUMAHumacyte, Inc. · Stock Purchase
$15,001 - $50,000
Apr 8, 2022 Mar 30, 2022 Filing ↗

Whale Activity

Position changes in HUMA reported for 2026-09-30 by 176 institutional filers
Increased: 38New: 12Held: 39Decreased: 38Closed: 46No prior filing: 3
  • Increased38
  • New12
  • Held39
  • Decreased38
  • Closed46
  • No prior filing3
FilerSharesValueChange
VANGUARD CAPITAL MANAGEMENT LLC11.0M$5.7Mincreased
ANTIPODES PARTNERS Ltd8.3M$4.3Mdecreased
BlackRock, Inc.4.6M$2.4Mdecreased
GREAT POINT PARTNERS LLC3.8M$1.9Mheld
MARSHALL WACE, LLP3.0M$1.6Mincreased
UBS Group AG3.0M$1.6Mincreased
GEODE CAPITAL MANAGEMENT, LLC2.7M$1.4Mincreased
CITADEL ADVISORS LLC1.7M$897Kincreased
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.7M$865Kdecreased
VANGUARD FIDUCIARY TRUST CO1.6M$829Kincreased
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.4M$712Kincreased
Endowment Wealth Management, Inc.105.4K$505Kheld

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by HUMA insiders, by quarter · Form 4
-2.5M-1.3M01.3M2.5M2025 Q1: 02025 Q12025 Q2: 106.0K2025 Q22025 Q3: -2.2M2025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: -24.0K2026 Q22026 Q3: 50.0K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

163 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Jones Keith AnthonyDirector Purchase +10.0K $0.56 $6K Sep 14, 2026 Form 4 ↗
Jones Keith AnthonyDirector Purchase +10.0K $0.69 $7K Aug 20, 2026 Form 4 ↗
Jones Keith AnthonyDirector Purchase +30.0K $0.59 $18K Aug 17, 2026 Form 4 ↗
Sebelius KathleenDirector Purchase +56.8K $0.88 $50K May 19, 2026 Form 4 ↗
Parikh Shamik JChief Medical Officer Sale −45.9K $0.90 $41K May 18, 2026 Form 4 ↗
Sander Dale A.CFO and Chief Corp. Dev. Off Sale −45.9K $0.90 $41K May 18, 2026 Form 4 ↗
Constantino Michael T.Director Purchase +11.0K $0.89 $10K May 18, 2026 Form 4 ↗
Sander Dale A.CFO and Chief Corp. Deve. Off. Grant / award +311.1K $0.00 $0 Nov 16, 2025 Form 4 ↗
Parikh Shamik JChief Medical Officer Grant / award +311.1K $0.00 $0 Nov 16, 2025 Form 4 ↗
Dougan Brady WDirector Sale −591.7K $1.58 $935K Aug 20, 2025 Form 4 ↗
Niklason Laura EPresident, CEO and Director · Director Sale −591.7K $1.58 $935K Aug 20, 2025 Form 4 ↗
Dougan Brady WDirector Sale −1.1M $1.63 $1.8M Aug 19, 2025 Form 4 ↗
Niklason Laura EPresident, CEO and Director · Director Sale −1.1M $1.63 $1.8M Aug 19, 2025 Form 4 ↗
Dougan Brady WDirector Sale −549.4K $1.83 $1.0M Aug 18, 2025 Form 4 ↗
Niklason Laura EPresident, CEO and Director · Director Sale −549.4K $1.83 $1.0M Aug 18, 2025 Form 4 ↗
Scheessele William JohnChief Commercial Officer Purchase +6,493 $1.54 $10K Apr 14, 2025 Form 4 ↗
Sander Dale A.CFO and Chief Corp. Deve. Off. Purchase +20.0K $1.53 $31K Apr 10, 2025 Form 4 ↗
Parikh Shamik JChief Medical Officer Purchase +7,500 $1.55 $12K Apr 10, 2025 Form 4 ↗
Sebelius KathleenDirector Purchase +50.0K $1.32 $66K Apr 8, 2025 Form 4 ↗
Green Charles BruceDirector Purchase +6,000 $1.29 $8K Apr 8, 2025 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding HUMA · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
7.7M$6.0M0.00%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.1M$1.7M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
1.6M$1.3M0.00%Apr 30, 2026
iShares Biotechnology ETF
iShares Trust
1.4M$1.1M0.01%Jun 30, 2026
VANGUARD RUSSELL 2000 INDEX FUND
VANGUARD SCOTTSDALE FUNDS
835.7K$1.1M0.01%May 31, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
969.6K$583K0.00%Aug 31, 2026
Schwab U.S. Small-Cap ETF
SCHWAB STRATEGIC TRUST
860.9K$518K0.00%Aug 31, 2026
VANGUARD HEALTH CARE INDEX FUND
VANGUARD WORLD FUND
575.4K$346K0.00%Aug 31, 2026
Schwab Small-Cap Index Fund
SCHWAB CAPITAL TRUST
370.4K$312K0.00%Apr 30, 2026
Schwab Total Stock Market Index Fund
SCHWAB CAPITAL TRUST
415.2K$271K0.00%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list HUMA's shares (CUSIP 44486Q103), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Fresenius Medical Care AGSCHEDULE 13D/A · activist (13D) · 13.6M shares4.9%
    Aug 18, 2026 · ↗
  • Fresenius Medical Care Holdings, Inc.SCHEDULE 13D/A · activist (13D) · 13.6M shares4.9%
    Aug 18, 2026 · ↗
  • BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 4.1M shares1.5%
    Jul 28, 2026 · ↗
  • Fresenius Medical Care AGSCHEDULE 13D/A · activist (13D) · 18.3M shares6.8%
    Jul 13, 2026 · ↗
  • Fresenius Medical Care Holdings, Inc.SCHEDULE 13D/A · activist (13D) · 18.3M shares6.8%
    Jul 13, 2026 · ↗
  • Anthony A. YoseloffSCHEDULE 13G · passive (13G) · 12.8M shares4.7%
    Jun 22, 2026 · ↗
  • Davidson Kempner Capital Management LPSCHEDULE 13G · passive (13G) · 12.8M shares4.7%
    Jun 22, 2026 · ↗
  • Davidson Kempner Arbitrage, Equities & Relative Value LPSCHEDULE 13G · passive (13G) · 12.6M shares4.7%
    Jun 22, 2026 · ↗
  • M.H. Davidson & Co.SCHEDULE 13G · passive (13G) · 232.7K shares0.1%
    Jun 22, 2026 · ↗
  • Fresenius Medical Care AGSCHEDULE 13D/A · activist (13D) · 18.3M shares6.8%
    Jun 15, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming humacyte as client
$0$50K$100K$150K$200K2023 Q1: $10K20232024 Q1: $10K2024 Q2: $10K2024 Q3: $20K2024 Q4: $20K20242025 Q1: $10K2025 Q2: $10K2025 Q3: $50K2025 Q4: $50K20252026 Q1: $50K2026 Q2: $50K2026 Q3: $50K2026
  • CAPITOL HILL CONSULTING GROUPHUMACYTE · 2026 Q3 · MMM, HCR, DEF$50K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPHUMACYTE · 2026 Q2 · MMM, HCR, DEF$50K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPHUMACYTE · 2026 Q1 · MMM, HCR, DEF$50K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPHUMACYTE · 2025 Q4 · MMM, HCR, DEF$50K
    Filing ↗
  • CAPITOL HILL CONSULTING GROUPHUMACYTE · 2025 Q3 · MMM, HCR, DEF$50K
    Filing ↗

Government Contracts

Federal awards to Humacyte, Inc. · USAspending

No federal contract awards found for Humacyte, Inc..

U.S. Patents

Recent USPTO applications naming Humacyte, Inc.

No USPTO patent applications found for Humacyte, Inc..

Annual Financials

From HUMA's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$2.0M$0n/an/an/a
Operating income-$108.1M-$114.4M-$100.0M-$84.6M-$81.2M
Net income-$40.8M-$148.7M-$110.8M-$12.0M-$26.5M
Diluted EPS-$0.26-$1.26-$1.07-$0.12-$0.66
Operating cash flow-$105.0M-$98.1M-$73.3M-$71.1M-$81.2M
Cash and equivalents$50.5M$44.9M$80.4M$149.8M$217.5M
Total assets$116.4M$137.9M$128.2M$204.3M$286.5M
Total liabilities$113.3M$190.5M$114.7M$87.4M$164.4M
Shareholders' equity$3.1M-$52.7M$13.5M$116.9M$122.2M

As Humacyte, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 27, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in HUMA's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 10, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureSep 28, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 12, 2026
    EDGAR ↗
  • 8-K · Items 3.01Delisting noticeJul 31, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureJun 11, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsJun 10, 2026
    EDGAR ↗
  • 8-K · Items 5.03, 5.07, 9.01Bylaw amendment · Shareholder voteJun 9, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJun 5, 2026
    EDGAR ↗
  • 8-K · Items 3.01Delisting noticeMay 8, 2026
    EDGAR ↗

About Humacyte, Inc.

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersDURHAM, NC
IncorporatedDE
Former namesAlpha Healthcare Acquisition Corp.